Patricia Chavez

ORCID: 0000-0001-6786-4952
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Cardiac Structural Anomalies and Repair
  • Mechanical Circulatory Support Devices
  • Transplantation: Methods and Outcomes
  • Cardiovascular Function and Risk Factors
  • Cardiac electrophysiology and arrhythmias
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Valve Diseases and Treatments
  • Cardiac Arrhythmias and Treatments
  • Cardiovascular Health and Risk Factors
  • Cardiac Arrest and Resuscitation
  • Blood Pressure and Hypertension Studies
  • Cardiac pacing and defibrillation studies
  • Nutrition and Health in Aging
  • Infective Endocarditis Diagnosis and Management
  • Cardiovascular Syncope and Autonomic Disorders
  • Renal Transplantation Outcomes and Treatments
  • Heart Failure Treatment and Management
  • Acute Myocardial Infarction Research
  • Ultrasound in Clinical Applications
  • Viral Infections and Immunology Research
  • Cardiovascular Issues in Pregnancy
  • Radiation Dose and Imaging
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Health and Disease Prevention

Montefiore Medical Center
2014-2024

Albert Einstein College of Medicine
2014-2024

Mexican Social Security Institute
2023-2024

Yale New Haven Health System
2024

Yale University
2024

International Society for Heart and Lung Transplantation
2024

IFC Research (United Kingdom)
2024

North Shore University Hospital
2019

Northwell Health
2019

St. Luke's Hospital
2014-2016

Hypertensive disorders of pregnancy (HDP) complicate 13% to 15% pregnancies in the United States. Historically marginalized communities are at increased risk, with preeclampsia and eclampsia being leading cause death this population. Pregnant individuals HDP require more frequent intensive monitoring throughout antepartum period outside routine standard care prenatal visits. Additionally, acute rises blood pressure often occur 3 6 days postpartum challenging identify treat, as most usually...

10.1016/j.jacadv.2024.100864 article EN cc-by-nc-nd JACC Advances 2024-02-21

Data from randomized controlled trials suggest that treating hypertension in the elderly, including octogenarians, may substantially reduce risk of cardiovascular disease and death. However, treatment remains challenging because comorbidities aging-related changes. We present common case scenarios encountered while managing elderly patients with hypertension, secondary adverse effects drugs, labile orthostatic hypotension, dementia.

10.3949/ccjm.79a.12017 article EN Cleveland Clinic Journal of Medicine 2012-10-01

Primary graft dysfunction (PGD) increases morbidity and mortality after heart transplant. Here we investigated (1) the association of continuous-flow left ventricular assist device (CF-LVAD), amiodarone, severe PGD (2) safety amiodarone discontinuation in CF-LVAD patients.Retrospective, single-center study transplant recipients was conducted to investigate risk factors PGD. Patients were grouped into 4 groups based on presence (denoted +) or absence -) CF-LVAD. Prospective undertaken its a...

10.1097/txd.0000000000001281 article EN cc-by-nc-nd Transplantation Direct 2022-01-13

ABSTRACT Microvascular dysfunction (MVD) is considered a form of cardiac allograft vasculopathy (CAV), independently associated with poor prognosis after heart transplantation (HTX). It unknown whether traditional risk factors for CAV are also applicable to MVD. We retrospectively analyzed MVD in 94 HTX recipients who completed PET scan normal baseline left catheterization excluding epicardial CAV. was defined by abnormal blood flow. The mean age 52 ± 14 and found 49 patients (53%). No donor...

10.1111/ctr.15445 article EN Clinical Transplantation 2024-10-01

Introduction: Timely involvement of palliative care services for patients with advanced heart failure (HF) improves symptom burden, functional status, and resource utilization. The Karnofsky Performance Scale (KPS) is an objective tool used by specialists to assess physical ability guide interventions. Patients lower KPS have poor outcomes, however evidence linking clinical parameters such as New York Heart Association (NYHA) class, ejection fraction (EF), albumin remains limited. Goals: To...

10.1161/circ.150.suppl_1.4147609 article EN Circulation 2024-11-11

Introduction: Palliative care interventions for patients with heart failure have been shown to significantly improve quality of life, reduce symptom burden, and enhance functional status. Timing referral becomes challenging as disease progresses readmission rates increase. We studied factors associated inpatient mortality in end stage failure, ineligible additional advanced therapies. Methods: Individuals acute decompensated admitted between 2021-2023, who were further cardiac therapies...

10.1161/circ.150.suppl_1.4143804 article EN Circulation 2024-11-12

Introduction: Hispanic/Latino individuals are known to have higher traditional cardiovascular disease (CVD) risk factors compared non-Hispanic Whites and Asians. However, inconsistencies variability exist regarding the incidence of heart failure (HF) among Hispanics other race/ethnic groups. We examined HF in participants enrolled Hispanic Community Health Study/Study Latinos (HCHS/SOL). Methods: The baseline HCHS/SOL population consisted 16,415 between 2008 - 2011 followed up for incident...

10.1161/circ.150.suppl_1.4147544 article EN Circulation 2024-11-12

Introduction: We assessed whether a longitudinal association between change in glucose homeostasis and cardiac structure function was present. Methods: Data from ECHO-SOL baseline visit 2 exams were used including 1643 Hispanic/Latino participants aged 45-74 years with serial echocardiograms obtained on average 4.3 (2.8-6.7) apart. Glucose hoemostasis evaluated through fasting plasma levels (FGP), hour oral tolerance test (OGTT) hemoglobin A1C (A1C) . categorized as: normal (NGT) (FPG<100...

10.1161/circ.145.suppl_1.010 article EN Circulation 2022-03-01
Coming Soon ...